American Conference Institute (ACI) is currently accepting speaker submissions for our upcoming Life Sciences/Healthcare Collaborations and Joint Ventures conference which will take place on November 30- December 1, 2016 at the Omni Parker House in Boston.
AmericanConference.com/LTCLitigation Join Us on Linkedin: ACI Healthcare: Legal, Regulatory, and Compliance Experts Follow Us on Twitter: @ACI_Health To join the conversation use #LTCare
By: Heather Landi, Published on Healthcare Informatics on December 16, 2015 While the healthcare industry has the most data breaches involving protected health information (PHI), 90 percent of all industries have experienced a PHI-related data breach in the past 10 years, according to a Verizon Enterprise Solutions study report. Also among the study findings, unencrypted lost and stolen devices,…
Healthcare/Long Term Care – The latest updates on whistleblowing, managing caregiver stress, long term care litigation, and more
NEW YORK – Nov. 6, 2015 – PRLog — American Conference Institute (ACI) is pleased to announce Dr. Ronald A. Kline will be delivering a Keynote Address “View from the front lines in the battle of wound care: They don’t know what they don’t know” at ACI’s 6th Annual Long Term Care Litigation and Risk Management Strategies conference which will take…
NEW YORK – Oct. 15, 2015 — American Conference Institute (ACI) is pleased to announce that Peter Neumann, director of the Tufts Center for Evaluation of Value and Risk in Health will be the keynote speaker at ACI’s second annual Legal, Regulatory, Business and Compliance Forum on Health Outcomes Data Communications, Market Access and Contracting which will take…
Pharma & Healthcare – Pfizer chansing AstraZeneca, FDA okays start of BrainStorm stem cell trial in ALS patients and more.
Pharma & Healthcare – the latest on the FDA move towards the way it approves OTC meds, Walgreens, UnitedHealth, and more to share patient date and more. Steering for a U.S. comeback, AstraZeneca’s Brilinta runs aground on DoJ investigation by Tracy Staton Published on Fierce Pharma Marketing Here’s a scenario: You’re trying to jump-start sales of…
Pharma & Healthcare – the latest on the FDA and Xarelto, TPG and Chindex’s deal and more. No FDA love for Xarelto in ACS patients by Carly Helfand Published on FiercePharma Looks like the FDA has taken an advisory committee’s Xarelto concerns to heart. Following up on an overwhelming “no” vote from last month, the agency Friday issued Johnson &…
Pharma & Healthcare – the latest on medical product development, Sanofi’s Lemtrada drug, FDA approval and more. Preparing for a “New Era of Medical Product Development” by Eitan Bernstein, Carolyne Hathaway, John Manthei Published on jdsupra.com FDA report demonstrates support for personalized medicine and more efficient regulatory pathways. In a new report issued by the Food and Drug Administration…
Expert Article by Office of Governor Edmund G. Brown Jr. Governor Edmund G. Brown Jr. today proposed reforms to strengthen and restore the intent of Proposition 65, a three decade old law enacted to protect Californians from harmful chemicals, that has been abused by some unscrupulous lawyers driven by profit rather than public health. The administration,…